SHOEI Co., Ltd. acquired 406,700 shares of treasury stock totaling 700,882,900 yen from February 1 to February 27, 2026, and has completed the acquisition based on the board resolution dated November 14, 2025.
Recording of gain on sale of 2,000,000 shares of Ibiden Co., Ltd., amounting to 13.1 billion yen in the fiscal year ending March 2026.
Premium Water Holdings Co., Ltd. will issue the 11th series unsecured bonds with early redemption provisions worth 8 billion yen and the 12th series worth 2 billion yen on March 11, 2026, and plans to allocate proceeds to repayment of short-term borrowings and lease obligations.
The consolidated total sales for February of the fiscal year ending March 2026 amounted to 8,204 million yen, up 0.4% year-over-year. Same-store sales remained flat compared to the previous year.
For the fiscal year ending January 2026, consolidated net sales were 4,197.922 billion yen (3.4% year-over-year increase), operating income was 341.402 billion yen (3.0% year-over-year increase), and net income attributable to owners of parent was 232.095 billion yen (6.6% year-over-year increase). Share buyback cancellation of 11,700,000 shares is scheduled for April 24, 2026.
Formulated the 7th Medium-Term Management Plan covering FY2026 to FY2028. Plans total sales of JPY 13,905.0 billion, operating income of JPY 1,170.0 billion, and net income attributable to owners of parent of JPY 758.0 billion over three years. Dividends are planned with a floor of JPY 145 per share.
Sekisui House, Ltd. announced the scheduled cancellation of 11,700,000 common shares (1.76% of total shares issued) on April 24, 2026.
At the 75th Annual General Meeting of Shareholders scheduled for April 23, 2026, the appointment of nine director candidates (including one new) and two corporate auditor candidates (including one new) was resolved.
In February 2026, existing store sales YoY were 105.7% and total store sales YoY were 107.3%, exceeding guidance. Two new stores opened and seven stores underwent format conversion. The company received the Bronze Award in the Ministry of the Environment's ESG Finance Award.
Ono Pharmaceutical Co., Ltd. resolved at the Board meeting on March 5, 2026, to introduce a long-term incentive stock compensation plan equivalent to JPY 20,454 million and 8,398,300 shares for employees of its U.S. subsidiary, Deciphera Pharmaceuticals, Inc.
Total units for February 2026 were 118,263, with 95,651 units in operation, operating rate of 80.88%, and existing unit occupancy at 86.92%. The new unit operating rate was 35.21%, reflecting continued aggressive store expansion.
In the fiscal year ending March 2026, Juroku Bank, a subsidiary, plans to sell 1,740,000 shares of Ibiden Co., Ltd. for 12,726 million yen and record a gain on sale of 11,610 million yen.